Palisade Bio, Inc. (PALI)
NASDAQ: PALI · Real-Time Price · USD
2.130
+0.060 (2.90%)
At close: Aug 26, 2026, 4:00 PM EDT
2.130
0.00 (0.00%)
After-hours: Aug 26, 2026, 4:52 PM EDT

Palisade Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
37135055818
Market Cap Growth
5298.56%7572.39%-16.56%-31.77%-54.57%-
Enterprise Value
246345-3-9-54
Last Close Price
2.072.351.658.8578.00975.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
742.39--21.88--
PB Ratio
2.952.710.610.480.642.40
P/TBV Ratio
3.052.710.610.480.642.40

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-0.000.020.030.030.03
Net Debt / Equity Ratio
-1.03-1.03-1.29-1.07-0.96-1.40
Net Debt / EBITDA Ratio
3.547.390.650.940.780.88
Net Debt / FCF Ratio
6.8812.290.791.080.900.70
Asset Turnover
0.01--0.02--
Quick Ratio
23.9628.833.044.874.594.26
Current Ratio
24.2628.953.245.154.894.61
Return on Equity (ROE)
-51.37%-24.52%-153.56%-103.40%-143.72%-20012.03%
Return on Assets (ROA)
-32.98%-15.54%-74.50%-53.85%-67.69%-94.46%
Return on Capital Employed (ROCE)
-29.00%-13.90%-194.40%-112.00%-120.10%-117.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-8.60%-4.79%-316.35%-224.87%-177.89%-150.84%
FCF Yield
-4.90%-3.10%-267.16%-203.61%-166.78%-83.72%
Buyback Yield / Dilution
-4683.09%-3830.18%-210.62%-677.03%-370.85%-
SEC Filings: 10-K · 10-Q